Microbial Exposure and Onset of Allergic Diseases - Potential Prevention Strategies?  by Pfefferle, Petra Ina & Renz, Harald
Allergology International Vol 63, No1, 2014 www.jsaweb.jp 3
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Allergic Diseases
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ABSTRACT
Chronic inflammatory diseases are a major health problem with global dimension. Particularly, the incidence of
allergic diseases has been increased tremendously within the last decades. This world-wide trend clearly indi-
cates the demand for new approaches in the investigation of early allergy development. Recent studies under-
lined the basic postulate of the hygiene hypothesis that early exposure to microbial stimuli plays a crucial role in
the prevention of chronic inflammatory conditions in adulthood. There is ample evidence that, both, exogenous
microbes and endogenous microbial communities, the human microbiota, shape the developing immune sys-
tem and might be involved in prevention of pathologic pro-inflammatory trails. According to the Barker hypothe-
sis, epidemiological studies pointed to transmaternal transmission from the mother to the offspring already in
prenatal life. Experimental data from murine models support these findings. This state of the art review pro-
vides an overview on the current literature and presents new experimental concepts that point out to future ap-
plication in the prevention of allergic diseases.
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ABBREVIATIONS
CID, chronic inflammatory disease; GF, germ-free; IgE, immunoglobulin E; IL, interleukin; IFN-γ, interferon-γ;
LPS, lipopolysaccharide; NO2, nitrogen dioxide; SO2, sulfur dioxide; TH, T-helper; TLR, toll-like-receptor; TNF-
α, tumor necrosis factors α.
ALLERGIES - A HEALTH PROBLEM OF
GLOBAL DIMENSION
Chronic inflammatory diseases (CID) represent a
complex of multi-faceted non-communicable medical
conditions manifesting in nearly all organs. Though
the pathogenetic trails of CID differ between the
organ-specific manifestations, these conditions share
the same basic principle - a deviation of the immune
response. As a result of a persistently dysbalanced
immune defence chronic inflammation appears within
a characteristic window of aging, depending on the
specific outcome. The major part of CID, e.g. inflam-
matory bowel diseases or multiple sclerosis, is in-
itially manifested in late childhood, puberty and ado-
lescence or later, while allergies uniquely appear al-
ready in early childhood. In spite of different onsets
and courses, a global increase of incidence could be
noted for all in the last decades. This dramatic in-
crease in incidence cannot be explained solely by the
presence of genetic variants (e.g. polymorphisms) in
chronically diseased individuals which lead to a dys-
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balanced immune response. Such genetic variants
have been identified in a high number of genes in
various phenotypes of patients suffering from aller-
gies or autoimmune diseases.1-4
A general current concept to explain the increasing
health burden of CID is a close and intimate interac-
tion between genes of disease risk and environmental
factors. It is of major importance to identify and char-
acterize environmental components which are closely
associated with disease development and manifesta-
tion, since this could be a starting point not only for a
better understanding of the pathogenesis of these
conditions, but also for the development of (primary)
prevention strategies.5
Environmental factors may contribute to a develop-
ment of allergies in two different and antagonistic
ways: On the one hand environmental components
could be defined as risk factors for the development
of allergies. Particularly in the last century major re-
search efforts were undertaken to characterize and
define such risk factors. Hence, these efforts led to
the identification of passive and active tobacco
smoke, environmental pollutants such as SO2 and
NO2, psychological factors (e.g. chronic stress), nu-
tritional components and others as risk factors for the
development andor exacerbation of allergic inflam-
mation.6-11
More recently an alternative approach has been un-
dertaken by several groups including our own re-
search laboratory that is the search for protective en-
vironmental components. Based on three fundamen-
tal hypotheses the hygiene hypothesis, the micro-
biota hypothesis and the Barker hypothesis, these ef-
forts led to the development of a new paradigm fo-
cussing around the role of environmental and barrier
microbes as early determining factors of immune de-
velopment. This article summarizes and highlights
recent findings which are discussed and presented in
a broader way in two recently published review arti-
cles by the authors.12,13
THE HYGIENE HYPOTHESIS
It was in the late 1980s that David Strachan published
the observation that children with older siblings and
or frequent early childhood infections showed a con-
sistent and significant protection, particularly against
respiratory allergies.14 In line with Strachan’s obser-
vations, increased exposure to early childhood patho-
gens was suggested as the major determinant that
protects children attending day care early in life
against the development of respiratory allergies.15,16
A similar allergo-protective effect was observed in
children living under unique lifestyle conditions e.g.
as defined by the term “anthroposophical” lifestyle
based on the Steiner concept,17 among the Amish
population in Northern America18 and in emerging
countries in populations with a poor hygienic stan-
dard.19,20 These findings were substantiated by nu-
merous studies conducted in traditional farming sites
such as traditional farms in the Alpine region of cen-
tral Europe.21 As a common thread, these living con-
ditions are characterised by a highly enriched micro-
bial environment. In the original sense of the hygiene
hypothesis, a frequent confrontation with environ-
mental microbes particularly in early childhood
shapes normal immune responses closely linked to
clinical and immunological tolerance. A number of
environmental microbes have recently been identi-
fied and further functionally characterized with re-
gard to their capacity to modulate immune responses
(see below).
THE MICROBIOTA HYPOTHESIS
Regardless whether environmental microbes are pri-
marily exposed to the respiratory, the gastrointestinal
of the skin mucosal surface, these microorganisms
may closely interact with the epithelial barrier and
the innate immune system. Some of them will suc-
cessfully colonize these surfaces and will make up
the mucosal microbiota, a sustainable microbial com-
munity established in symbiosis with the host. It has
recently been shown that these barrier microbes play
a pivotal role in shaping immune responses, particu-
larly early in life. These microbes apparently play a
decisive role in either generating (mucosal) tolerance
or leading the way to the development of inflamma-
tory conditions.22
The gastrointestinal microbiota represents the by
far best studied microbial community coexisting with
human subjects. This system consists of more than
100 trillion microorganisms, most of which are bacte-
ria. Two of about 55 known phyla (Firmicutes and
Bacterioidetes) dominate the human intestinal tract.
This illustrates the relative exclusivity of the human
intestinal microbiota, indicating the special relation-
ship between us and them. The individual micro-
biome consists of approximately 15% of the much
more than 1.000 thus far identified species.23,24
It has been just recently recognized that there is a
close bidirectional interaction between these micro-
biota and our immune system.25 Some microbes pro-
vide us with essential non nutrient factors such as vi-
tamins. We also benefit from their energy machinery,
which increases our harvest of nutrients in the gut.
Furthermore, of great importance is the fact that mi-
crobial triggers are necessary for the development
and maturation of our immune system, as recently
summarized in several review articles.26,27 In this re-
gard germ-free mice represent an important model
system to study the effect of (controlled and organ-
ized) colonization on the development of the innate
and adaptive immune system.28,29
Sudo et al.30 discovered that GF mice were not ca-
pable of developing oral tolerance against a model al-
lergen ovalbumin because of abrogation of TH1-
mediated responses. In consequence, GF mice had
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stronger T-helper (TH)2-responses, as demonstrated
by increased production of interleukin (IL)-4. Recon-
stitution of the intestinal flora with the predominant
intestinal bacterium B. infantis completely restored
oral tolerance induction to a TH2-promoting allergen.
Interestingly, this mechanism was only effective
when the reconstitution was performed in neonates
but not in adult mice. A similar observation has been
found using sensitization to cow’s milk protein.31 Fur-
thermore there seems to be a close interaction be-
tween the intestinal immune responses and the lung.
Missing or altered intestinal colonization has an im-
pact on respiratory immune responses. Herbst et al.
could demonstrate that GF mice exhibited exagger-
ated allergic immune responses in the lung after in-
tranasal allergen challenge of sensitized animals.
Such animals showed increased eosinophil and baso-
phil numbers, which correlated with augmented local
TH2 cytokine production, systemic IgE levels, de-
creased alveolar macrophage plasmacytoid dendritic
cell numbers and an altered phenotype of conven-
tional dendritic cells. Also, recolonization with the
complex flora of normofloral mice could completely
reverse the exaggerated and augmented allergic re-
sponses found in germ-free (GF) mice.32 Intact toll-
like-receptor (TLR) signalling pathways, together
with triggering of these pathways via microbial recog-
nition seems to be an important prerequisite in order
to shape intestinal homeostasis.33,34 On the other
hand, GF mice could be protected from cow’s milk al-
lergy by a transfer of infant human gut microbiota
with a predominant presence of Bifidobacterium and
Bacteroides species.35 These are just some of many ex-
amples indicating the importance of gut microbes on
the development of immunological homeostasis not
only on the local level, but also in terms of systemic
responses and responses at other anatomical sides.
Furthermore, it is important to note that there is ap-
parently a certain “Window of opportunity” where
these programming events can occur in a very effi-
cient way. Both human and animal studies point to
the perinatal environment as a very critical period in
life in this regard.
ENVIRONMENTAL MICROBES AND ALLER-
GIES
One of the best studied model situations for clinical
and experimental evaluation of the hygiene hypothe-
sis is the traditional farming environment. Here it was
shown that living under these conditions results par-
ticularly in a marked reduction of incidence and
prevalence of respiratory allergies and atopic sensiti-
zation. This has been repeated and reproduced now
in quite a number of independent studies (reviewed
in21).
EXPOSURES ASSOCIATED WITH THE PRO-
TECTIVE EFFECT
One important component in this regard is the expo-
sure to animals raised on farms.36 The higher the
number of species exposed to the stronger is the
asthma-protective effect. Particularly exposure to
cows seems to be of great importance.37 In addition,
nutritional components have also been identified.
Drinking non-pasteurised, non-homogenised milk
and consuming dairy products also seems to be quite
helpful.38
The first bacterial component which has been
linked to asthma protection is the exposure to endo-
toxinlipopolysaccharide (LPS), cell wall components
of gram-negative bacteria. LPS-exposure was meas-
ured in dust samples collected from mattresses as a
surrogate marker for continuous chronic exposure to
bacteria. An inverse correlation was found between
the dose of exposure and the protective effect. The
higher the natural exposure dose the stronger the
protective effect or the lower the risk for the develop-
ment of respiratory allergies, atopic sensitization and
other phenotypes. Additional assessments were then
performed using mononuclear cells collected at
school age and polyclonally stimulated for 24 hours.
Measurements of cytokines reveal a strong down
regulation of cytokine production with increasing
doses of natural LPS-exposure. This was found for
proinflammatory cytokines such as tumor necrosis
factor (TNF)-α, interferon (IFN)-γ, and IL-10 and oth-
ers, reflecting a state of “endotoxin tolerance” at
school age with increasing exposure dose.39
LPS is recognized by pattern recognition receptors
of the TLR-family. It was therefore the next step to an-
alyse a TLR-expression pattern in association with en-
dotoxin exposures. It was found that early life expo-
sures have a strong effect on the TLR-expression as
indicated by increased TLR5 and TLR9 mRNA levels
at birth. The higher the number of different farm ani-
mal species the mother had contact with during preg-
nancy, the higher the levels of TLR2, TLR4 and CD14
at school age.40
THE “FOETAL ORIGIN OF DISEASE” HY-
POTHESIS
In the early 90th of last century the epidemiologist
David Barker postulated that foetal developmental
programming is modified by environmental factors
which are transmitted from the mother to the prog-
eny. Based on observations he made in large birth co-
hort studies Barker suggested that modification of
foetal programming caused by prenatal exogenous
exposures will lay the foundation for later pathogenic
conditions in adulthood such as cardio-vascular or
metabolic diseases.41
Recently, this concept was broadened by new evi-
dence that microbial prenatal exposures play a pivotal
Pfefferle PI et al.
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Table　1　The asthma protective effect of bacterial strains and bacterial components in experimental models of murine airway 
infl ammation
A
Sensitisation 
with HDM
Alum i.p. without Alum s.c. i.n.
Postnatal exposure to: A. lwoffii F78 i.n.51
L. lactis 
G121 i.n.51
B. lichini-
formis 
467 i.n.52
E. coli 
i.n.51
S. scuiri 
W620 i.n.53
A. lwoffii 
F78 i.n.56
L. rhamnosus 
GG neonatal 
i.n.60
S. scuiri 
W620 i.n.53
1) BAL:
Leukocytes ↓↓ ↓↓ ↓ ↓↓ ↓↓↓ ↓↓ ↓ ↓↓
Eosinophils ↓↓↓ ↓↓↓ ↓↓↓ ↓↓↓ ↓↓↓ ↓↓↓ ↓ ↓↓↓
Lymphocytes 0 ↓ 0 ↓ ↓↓ ↓↓ 0 ↓↓
2) Immunoglobulines:
anti-OVA IgE 0 0 n.d. n.d. ↓↓ ↓ ↓ n.d.
anti-OVA IgG1 ↓↓ ↓↓ n.d. ↓↓ ↓↓ ↓↓ 0 0
anti-OVA IgG2a 0 0 n.d. 0 ↑↑ ↑↑ 0 0
3) Airway reactivity ↓↓↓ ↓↓↓ ↓↓ ↓↓↓ ↓↓↓ 0 0 n.d.
4) Infl ammation (Histology) ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓ ↓↓↓
As compared to OVA or house dust mite extract respectively.
B
Prenatal exposure to: A. lwoffii F78 i.n.54
L. lactis 
G121 i.n.†
L. lactis 
G121 i.g.†
LPS 
i.n.48
L. rhamnosus GG i.g. 
pre- and perinatal 61
L. rhamnosus 
i.g. prenatal 48
S. scuiri 
W620 i.n.†
1) BAL:
Leukocytes ↓↓ 0 ↓ ↓↓↓ ↓↓ ↓ 0
Eosinophils ↓↓ 0 ↓ ↓↓ ↓↓↓ ↓ ↑
Lymphocytes ↓↓ 0 ↓↓ ↓↓ 0 ↑ ↑
Macrophages ↓ ↑ ↓ ↑↑ ↑ ↑ 0
2) Immunoglobulines:
anti-OVA IgE ↓ 0 0 ↓↓ 0 0 0
anti-OVA IgG1 ↓ 0 0 ↓↓↓ 0 0 0
anti-OVA IgG2a 0 0 0 ↓↓ 0 0 0
3) Airway reactivity ↓↓ 0 ↓↓ 0 0 0 0
4) Infl ammation (Histology) ↓ 0 ↓↓ ↓↓ ↓↓ ↓↓ ↑
As compared to OVA.
(A) Postnatal model of murine allergic airway infl ammation: Female BALB/c mice were exposed to PBS (control) or bacterial strains (see 
below) over the whole sensitization and challenge process. After challenge the asthmatic phenotype was analyzed. Protocol for bacterial
application: 1 × 108  CFU, 3 times per week starting directly after birth over the whole sensitization and challenge process. 1) Numbers of 
total leukocytes, eosinophils, lymphocytes (reduction of respective cells) in bronchoalveolar lavage (BAL). 2) Concentration of anti-OVA IgE, 
anti-OVA/HDM IgG1 (decrease of respective antibody titer) and anti-OVA/HDM-IgG2a (increase of respective antibody titer) in serum of off-
spring. 3) Airway responsiveness to methacholine (MCH) measured by head-out body-plethysmography. Shown is MCH50 (improvement of
airway reactivity). 4) Quantifi cation of infl ammation in airways (reduction of infl ammatory cells). 0 = 0%; ↑ > 0-33%; ↑↑ > 34-66%, 
↑↑↑ > 67-100%. †own unpublished data.
(B) Prenatal model of murine allergic airway infl ammation: Female BALB/c mice were exposed to PBS (control), LPS or bacterial strains 
(see below). Offspring were sensitized to ovalbumin (OVA), OVA aerosol challenged and the asthmatic phenotype was analysed. Protocol 
for bacterial application: 1 × 108  CFU, i.n., 3 times per week starting 10 days before mating until birth of the offspring. Protocol for LPS ap-
plication: 1 × 108 CFU, 3 times per week starting 10 days before mating until birth of the offspring. 1) Numbers of total leukocytes, eosino-
phils, lymphocytes (reduction of respective cells) and macrophages (increase of respective cells) in bronchoalveolar lavage (BAL). 2) Con-
centration of anti-OVA IgE, anti-OVA IgG1 (decrease of respective antibody titer) and anti-OVA-IgG2a (increase of respective antibody titer) 
in serum of offspring. 3) Airway responsiveness to methacholine (MCH) measured by head-out body-plethysmography measured as MCH50 
(improvement of airway reactivity). 4) Quantifi cation of infl ammation in airways (reduction of infl ammatory cells). ↓ > 0-33%; 0 = 0%; ↑ > 
0-33%; ↑↑ > 34-66%, ↑↑↑ > 67-100%. †own unpublished data.
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Fig.　1　Early environmental microbial stimuli contribute to immune tolerance and protection 
against chronic infl ammatory conditions in adulthood - “window of opportunity”. Already in 
fetal life transmaternally submitted environmental stimuli affect the developing immune 
system of the offspring. After birth the microbiota seems to play a decisive role in shaping 
the neonate immune response with consequences for later immune homeostasis or chronic 
infl ammatory conditions in adulthood. Within an early window of opportunity application of 
microbes or microbial components seems to be promising tool in preventive and therapeutic 
strategies against the development of chronic infl ammatory diseases.
role in shaping and programming early immune re-
sponses and thereby later chronic inflammatory con-
ditions. Maternal exposure to a diverse microbial en-
vironment (as found on traditional farming sites) dur-
ing the early life window of pregnancy was shown to
be associated with a TH1 balanced immune re-
sponses of the progeny at birth. Already in cord
blood, a consistent upregulation and increased pro-
duction of IFN-γ and TNF-α at birth has been found
while no effect on TH2-cytokine levels or IL-10 or IL-
12 production could be detected.42 Furthermore, an
inverse relationship between neonatal IgE-production
and cord blood IFN-gamma levels was noted.43 These
data have shed important light on regulation of peri-
natal adaptive immune responses. It is now estab-
lished that the prenatal period is characterized by a
marked upregulation of TH2 immune responses.
Many reasons may account for this phenomenon, in-
cluding the prevention of abortion and rejection for
the maternal immune system, the ability to recognize
very low antigen concentrations as well as the preven-
tion of unwanted inflammatory responses.44 However,
it is an important task to stimulate the TH1-immune
pathway very early on in life. This is of great impor-
tance since the type 1 immune responses within the
CD4 and CD8-subsets are very critical for the defence
of viral, bacterial and also fungal infections. It is,
therefore, critical that the developing immune system
trains the type 1 pathway in a way that this is becom-
ing the preferred pathway instead of the TH2 system.
Though microbial exposures during pregnancy
might at the end alter adaptive immune responses, in-
nate immune cells seem to act as crucial initiators of
this interplay. As an important step further in under-
standing this mechanism it could be demonstrated
that local (mucosal) administration of natural or syn-
thetic TLR agonists trigger a cascade of immune re-
sponses which result in the protection of experimen-
tal asthma in several murine models. This has been
shown for TLR2 (lipopeptides),45 TLR24 (peptidogly-
can),46 TLR4 (lipopolysaccharides),47,48 TLR3 and
TLR7 (poly I:C and R848)49 and TLR9 agonists.50 In
most of these studies, the TH2-protective effect was
related to either a marked upregulation of type 1 im-
mune responses or increased levels of IL-12 and IL-
10.
Based on these experimental data, whole bacteria
were investigated instead of synthetic TLR ligands.
These bacteria were derived from the analysis of the
microbial content of dust samples collected on tradi-
tional farms. Tested in experimental models of
asthma and demonstrated in asthma protective effect
when administered repeatedly and through exposure
to mucosal surfaces: Acinetobacter lwoffii, Lactobacil-
lus lactis, Bacillus licheniformis and Staphylococcus sci-
uri.51-54 In between a number of farm-derived bacteria
Pfefferle PI et al.
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were investigated for their allergoprotective capacity.
These studies have shown that microbial protection
is provided pre- and postnatally and both via the inha-
lative and the digestive route (see Table 1). Further
studies are on their way to delineate the underlying
regular mechanism which lead to these protective ef-
fects on both sides, namely the maternal and the
materno-fetal interface as well as events operating in
the neonate itself.55
OPPORTUNITIES FOR PREVENTION AND
INTERVENTION WITH MICROBES
It was more than 10 years ago that the first reported
clinical trial using probiotics was published in terms
of allergy prevention. Since then most of the studies
focussed primarily on early outcomes of allergic dis-
eases such as eczema and IgE-mediated food aller-
gies with far fewer looking at longer-term outcomes
of the atopic marge such as respiratory allergies. Un-
fortunately there is a high degree of inconsistencies
between findings from different studies. Many of
them can be attributed to the wide range of methodo-
logical heterogeneity which prevents direct compari-
son and meaningful meta-analysis. Differences in-
clude probiotic strains or combinations used in the
preparation, method of delivery, dose, inclusion crite-
ria, timing and duration of intervention and measure-
ment of clinical outcomes. Furthermore, the results
are conflicting even for those strains such as Lactoba-
cillus rhamnosus GG, which are most extensively
studied.56-59 This topic has been recently covered by
a review article.12 Most probably, interventions
should include both ante-natal and post-natal treat-
ment periods. Furthermore, there is still uncertainty
about the ideal bacterial strains used in the prepara-
tion. Also it is still open whether the general popula-
tion would benefit from such strategies or only high
risk infants. Further open questions include dosing,
timing of introduction and length of treatment.
Future intervention strategies might target the mi-
crobiota as a central immune compartment. The life-
saving strategy of faecal microbiota transplantation in
patients suffering from pseudomembranous colitis
points out to novel approaches in the prevention and
therapy of chronic inflammatory conditions.62
In conclusion, the close and intimate relationship
between man and bacteria seems to be established al-
ready in the mother’s womb and lasts up until adult-
hood. The most critical phase for immune dysbalance
and deviation seems to be the perinatal life span but
this interval also offers a “window of opportunity” to
intervent the early development of chronic inflamma-
tory conditions (Fig. 1).
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